Heron Therapeutics | HRTX - EPS Earnings Per Share


Heron Therapeutics reported $-0.02 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.





Eps Change Date
ALKERMES USD 0 0.4 Jun/2026
Alnylam Pharmaceuticals USD 1.84 0.15 Jun/2026
Amarin USD 0.14 0.06 Dec/2025
ANI Pharmaceuticals USD 2.21 0.16 Jun/2026
Anika Therapeutics USD 0.13 0.35 Dec/2025
Arrowhead Research USD -1.36 0.43 Jun/2026
Eisai JPY 64.71 76.24 Jun/2026
Emergent BioSolutions USD -0.77 0.29 Dec/2023
GlaxoSmithKline GBP 0.51 0.08 Jun/2026
Heron Therapeutics USD -0.02 0.02 Dec/2025
Insmed USD -0.06 0.7 Jun/2026
Ligand Pharmaceuticals USD 2.37 0.74 Jun/2026
Merck USD -0.13 1.15 Jun/2026
Nektar Therapeutics USD -1.78 0.43 Mar/2026
Neurocrine Biosciences USD 2.85 0.91 Jun/2026
Omeros USD -1.12 0.37 Jun/2024
Pacira USD 0.73 0.13 Jun/2026
Regeneron Pharmaceuticals USD 14.29 4.82 Jun/2026
Roche Holding CHF 10.98 2.61 Jun/2026
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Ultragenyx Pharmaceutical USD -0.9 0.94 Jun/2026
Veracyte USD 0.54 0.02 Jun/2026
Vertex Pharmaceuticals USD 4.73 0.26 Jun/2026